UNSPSC 85722320: Revision of autologous tissue substitute in left metatarsal-phalangeal joint, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in left metatarsal-phalangeal joint, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SWN47Z

UNSPSC 85722320 Revision of autologous tissue substitute in left metatarsal-phalangeal joint, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity. The recent opportunities posted under this code do not involve orthopedic tissue revision procedures or joint-level surgical interventions. Instead, the City of Phoenix Retirement Office solicited independent medical evaluation services for disability benefit determinations; the City of Long Beach sought surgical benefit program administration for Centers of Excellence networks; the Washington State Department of Transportation requested occupational medical surveillance; Harris County Juvenile Probation Department issued a request for information on emergency and specialty healthcare for detained youth; Collier County posted a pharmacy benefit management RFP; and the County of Santa Clara Health System qualified vendors for temporary health professional staffing across ancillary clinical categories. None of these opportunities align with the code's stated scope of autologous tissue revision in the first metatarsal-phalangeal joint.

The mismatch between the code's clinical specificity and the health services being procured suggests either a tagging error or a code assignment that does not reflect the work state and local governments are actually purchasing under this identifier. The posting bodies span state health systems, county retirement offices, county procurement agencies, and municipal departments across Arizona, California, Florida, and Washington—a broad geographic spread—but none are soliciting the orthopedic surgical procedure or tissue substitute revision that the code nominally describes. Business development professionals should verify whether this code is actively used for relevant state and local procurement before investing pursuit resources.